Cannabis

Canopy Rivers Portfolio Company Receives Approval to Research UV Light Impact on Cannabis Plant

BioLumic partners with JWC and Helius Therapeutics for cannabis research program TORONTO, Jan. 9, 2020 /PRNewswire/ -- Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF) portfolio company BioLumic Ltd. ("BioLumic") has received approval from the New Zealand Ministry of Health to apply it...

2020-01-08 20:00 4933

Canopy Growth Corporation Receives Major Project Status From The Australian Government

SMITHS FALLS, Ontario, December 3, 2019 /PRNewswire/ -- Canopy Growth Corporation, ("Canopy Growth"), with its medical division Spectrum Therapeutics, is pleased to announce that it's application for Major Project Status (MPS) has been granted by the Australian Federal Governments Department of ...

2019-12-03 11:42 770

Spectrum Therapeutics Partners with Emerald Clinics on Real World Evidence Research

VICTORIA, Australia, Nov. 11, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (Canopy Growth), is pleased to announce an Australian first for the company. Spectrum has partnered with Emerald Clinics Australia (Emerald Clinics) to collect ...

2019-11-11 05:00 622

Regulation Needs to Keep Pace With Global Cannabis Legalisation in 2019 - Prohibition Partners

LONDON, Aug. 22, 2019 /PRNewswire/ -- The number of countries to legalise medical cannabis has risen nine-fold in the last five years, as global attitudes towards cannabis have shifted in favour of liberalisation. In 2019, 43 countries have legalised medical cannabis, with a host more allowing p...

2019-08-22 19:54 1524

Spectrum Therapeutics partners with Canadian Mental Health Association's Not Myself Today® initiative

SMITHS FALLS, Ontario and TORONTO, July 10, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to announce a partnership with the Canadian Mental Health Association ("CMHA...

2019-07-10 20:00 7470

Spectrum Therapeutics provides update on its global clinical research program and unveils pharmacovigilance program

SMITHS FALLS, Ontario, June 5, 2019 /PRNewswire/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to share an update on its efforts to develop and commercialize validated cannabis medicin...

2019-06-05 19:00 6610

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

NESS ZIONA, Israel, May 27, 2019 /PRNewswire/ -- Ori Yehudai: "I took a company worth$3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants...

2019-05-27 20:05 1864

Canopy Growth Introduces Spectrum Therapeutics

SMITHS FALLS, Ontario, May 7, 2019 /PRNewswire/ -- Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all of the Company's ongoing medical and research operations including Sp...

2019-05-07 22:31 6342